The story of Viagra presents a intricate picture for shareholders. While the initial introduction generated substantial gains, the end of its intellectual property protection opened the avenue to cheaper alternatives, https://bookmarkingdepot.com/story21568202/the-copyright-and-big-pharma-a-volatile-bet